Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Author:
Affiliation:
1. Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea
2. Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea
3. Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea
Funder
Korea University
Publisher
The Editorial Office of Gut and Liver
Link
https://pdf.medrang.co.kr/GNL/2024/018/GNL018-02-305.pdf
Reference33 articles.
1. World Health Organization (WHO). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 [Internet]. Geneva: WHO; c2021 [cited 2023 Jan 1]. Available from: https://www.who.int/publications/i/item/9789240027077
2. History and future of hepatitis B virus control in South Korea
3. Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
4. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
5. Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3